omniture
logo
Search
ENERGENESIS BIOMEDICAL CO., LTD.
Media Room

Latest News

rss

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease

* The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled st...

2025-08-01 15:52 2082

Energenesis Biomedical to Unveil Promising Parkinson's Disease Therapy, ENERGI-F705PD, at BIO International 2025

TAIPEI, June 11, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-sta...

2025-06-11 15:58 1833